Yumanity Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.03%36.710.9%$1161.89m
JNJJohnson & Johnson -0.01%160.280.7%$1077.05m
LLYEli Lilly & Co. 0.01%190.791.1%$703.48m
ABBVAbbVie, Inc. -0.03%110.491.9%$703.16m
MRKMerck & Co., Inc. 0.00%83.380.7%$683.91m
BMYBristol-Myers Squibb Co. 0.03%66.561.0%$677.82m
AZNAstraZeneca Plc 0.00%51.341.2%$630.16m
ARCTArcturus Therapeutics Holdings, Inc. 0.00%59.690.0%$205.25m
VTRSViatris, Inc. 0.00%17.050.0%$192.05m
RPRXRoyalty Pharma Plc 0.00%51.950.2%$173.88m
NVSNovartis AG 0.00%95.630.2%$170.63m
GSKGlaxoSmithKline Plc -0.01%38.470.2%$140.21m
SNYSanofi 0.00%49.390.2%$113.78m
RGENRepligen Corp. 0.00%215.476.9%$75.65m
NVONovo Nordisk A/S 0.00%72.030.1%$70.83m

Company Profile

Yumanity Therapeutics, Inc. is a clinical stage biopharmaceuticals company. It is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform. Its platform is based on technology, which enables the rapid screening for novel disease targets and disease modifying drugs that can overcome toxicity in disease-causing gene networks, which usually results from an aberrant accumulation of misfolded proteins in the brain. The company was founded by Susan Lindquist and Tony Coles in December 2014 and is headquartered in Boston, MA.